Suppr超能文献

建立短期人脑肿瘤培养物的改进技术。

Improved technique for establishing short term human brain tumor cultures.

作者信息

Farr-Jones M A, Parney I F, Petruk K C

机构信息

Division of Neurosurgery, University of Alberta, Edmonton, Canada.

出版信息

J Neurooncol. 1999 May;43(1):1-10. doi: 10.1023/a:1006115608103.

Abstract

Culturing human central nervous system tumors has been difficult compared to other neoplasms. We report improved success rates for establishing short term human brain tumor cultures using a modified tissue processing technique. Eighty-seven brain tumor specimens (56 glioblastomas, 8 mid grade astrocytomas, 8 oligodendrogliomas, 15 other) were obtained from June 1988 to March 1997. The first twenty-three samples were processed by dissection, partial enzyme dissociation, and filtration through a tissue culture sieve. Subsequent samples were processed identically except tumor cells were centrifuged on a density gradient prior to plating. Successful cultures were defined as those surviving greater than three passages in tissue culture and growing to sufficient numbers (>10(6) cells) to allow freezing. Success rate was 42% (10/23) using standard processing methods and 86% (55/64) with the addition of density gradient centrifugation. Glial fibrillary acidic protein (GFAP) and vimentin staining, karyotypes, and growth curves were obtained for representative glioma cultures. All cultures tested were positive for vimentin (29/29) while 62% (18/29) were positive for GFAP. Of four cultures karyotyped (two glioblastomas, two oligodendrogliomas), all but one oligodendroglioma culture exhibited clonal cytogenetic abnormalities. These immunohistochemical and karyotypic results are consistent with the malignant glial origin of these cells. Of note, low passage human glioma cultures grew slower and exhibited more contact inhibition than immortalized human glioblastoma cell lines. Nevertheless, this simple method for establishing short term human brain tumor cultures should aid in further developing human brain tumor pre-clinical models as well as enhancing clinical applications dependent on in vitro human brain tumor cell growth adjust.

摘要

与其他肿瘤相比,培养人类中枢神经系统肿瘤一直很困难。我们报告了使用改良的组织处理技术建立短期人脑肿瘤培养物的成功率有所提高。1988年6月至1997年3月期间获取了87份脑肿瘤标本(56例胶质母细胞瘤、8例中级星形细胞瘤、8例少突胶质细胞瘤、15例其他类型)。最初的23个样本通过解剖、部分酶解离并通过组织培养筛过滤来处理。后续样本的处理方式相同,只是肿瘤细胞在接种前在密度梯度上进行了离心。成功的培养物定义为在组织培养中存活超过三代且生长到足够数量(>10⁶个细胞)以进行冷冻的培养物。使用标准处理方法的成功率为42%(10/23),添加密度梯度离心后的成功率为86%(55/64)。对代表性的胶质瘤培养物进行了胶质纤维酸性蛋白(GFAP)和波形蛋白染色、核型分析以及生长曲线测定。所有测试的培养物波形蛋白染色均为阳性(29/29),而62%(18/29)的GFAP染色为阳性。在进行核型分析的4个培养物(2例胶质母细胞瘤、2例少突胶质细胞瘤)中,除1例少突胶质细胞瘤培养物外,所有培养物均表现出克隆性细胞遗传学异常。这些免疫组织化学和核型分析结果与这些细胞的恶性神经胶质起源一致。值得注意的是,低传代的人类胶质瘤培养物生长较慢,并且比永生化的人类胶质母细胞瘤细胞系表现出更多的接触抑制。尽管如此,这种建立短期人脑肿瘤培养物的简单方法应有助于进一步开发人脑肿瘤临床前模型,并增强依赖体外人脑肿瘤细胞生长调节的临床应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验